Detection method of per- and polyfluoroalkyl substances in follicular fluid

Through liquid chromatography detection method, the problem of lack of perfluoro and polyfluoroalkyl substance detection methods in follicle fluid is solved, and the high sensitivity detection of 33 PFAS in follicle fluid is achieved, meeting the needs of female fertility research.

CN116840388BActive Publication Date: 2024-11-22XIN HUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202310819144.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-07-05
Publication Date
2024-11-22
Estimated Expiration
2043-07-05

AI Technical Summary

Technical Problem

The prior art lacks perfluoro and polyfluoroalkyl substance detection methods with high sensitivity and high selectivity in follicle fluids, especially in female fertility research.

Method used

The liquid chromatography detection method was used, and the reverse phase C18 chromatography column was used, and the mobile phase included aqueous ammonium acetate solution and acetonitrile. 33 perfluoro and polyfluoroalkyl substances in the follicle liquid were detected by gradient elution and electrospray ion source.

Benefits of technology

It realizes simple and fast detection of perfluoro and polyfluoroalkyl substances in follicle fluid, high sensitivity, low detection limit, strong versatility and good stability, and can accurately detect the concentration of 33 PFAS in follicle fluid.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116840388B_ABST
    Figure CN116840388B_ABST
Patent Text Reader

Abstract

The present invention discloses a method for detecting perfluoroalkyl and polyfluoroalkyl substances in follicular fluid. The method comprises: obtaining a follicular fluid sample; pre-treating the follicular fluid sample to obtain an injection sample; performing liquid chromatography detection on the injection sample to obtain a target compound; the conditions for the liquid chromatography detection are: a reverse phase C18 chromatographic column is used as a chromatographic column, and a mobile phase comprises a mobile phase A and a mobile phase B; the mobile phase A is 2 to 10 mmol L −1 The mobile phase B is acetonitrile; the mobile phase A and the mobile phase B are subjected to gradient elution; wherein the liquid phase chromatographic detection mass spectrometry conditions are: using an electrospray ion source; the target compound includes at least one of the 33 PFAS compounds. Through the solid phase extraction and liquid chromatography detection of follicular fluid, it has the characteristics of being simple and rapid, with a low detection limit, strong versatility, high sensitivity, stability and good reproducibility, and can detect the determination of 33 PFAS in follicular fluid.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of environmental detection and analysis, in particular to a method for detecting perfluoro and polyfluoroalkyl substances in follicular fluid. Background Art

[0002] Per- and polyfluoroalkyl substances (PFAS) are a class of synthetic compounds containing stable CF bonds with unique hydrophobic and oleophobic properties and antioxidant properties. Since 1950, PFAS have been widely used in various industrial production and consumer products, including chemicals, textiles, surfactants, cosmetics, food packaging materials and lubricants. PFAS are persistent and bioaccumulative, and are persistent organic pollutants that are widely present in various environments and enter organisms or the human body through air and dust inhalation, food ingestion, skin absorption, etc., posing health risks. Studies have shown that PFAS has multiple toxicities, such as immunotoxicity, genotoxicity, neurotoxicity, reproductive toxicity and carcinogenicity. PFAS can have adverse effects on female ovarian hormone levels and oocyte fertilization ability.

[0003] At present, when studying the effects of PFAS on female reproduction, the relationship between PFAS and female fertility is mainly explored by measuring the concentration of PFAS in serum. Follicular fluid is composed of factors secreted by granulosa cells and theca cells and plasma osmotic fluid, and plays an important role in the development and maturation of oocytes. Compared with serum, PFAS in follicular fluid is more closely related to female fertility.

[0004] There are many types of PFAS. As of now, there are more than 6,330 CAS numbers related to PFAS. PFAS mainly include traditional perfluorocarboxylic acids (PFCA), perfluorosulfonic acids (PFSA), PFAS precursors and PFAS substitutes. With the restrictions on the use of PFOS and PFOA issued by the Stockholm Convention in 2009 and 2015, the use of PFAS precursors and substitutes has increased year by year. When studying the effects of PFAS on female fertility, a variety of PFAS are worthy of attention. Therefore, accurate and sensitive determination of concentrations in follicular fluid is crucial to studying female fertility.

[0005] In recent years, detection methods for PFAS in plasma and serum have been widely developed, but there is still a lack of highly sensitive and selective detection methods for PFAS in follicular fluid, and even less of an analytical method that can simultaneously detect multiple perfluorinated compounds in follicular fluid. Summary of the invention

[0006] The technical problem to be solved by the present invention is to overcome the defect of the prior art in lacking a highly sensitive and highly selective detection method for detecting PFAS in follicular fluid, and to provide a method for detecting perfluoro and polyfluoroalkyl substances in follicular fluid.

[0007] The present invention solves the above technical problems through the following technical solutions:

[0008] Provided is a method for detecting perfluoroalkyl and polyfluoroalkyl substances in follicular fluid, the detection method comprising:

[0009] Obtaining a follicular fluid sample:

[0010] The follicular fluid sample is pretreated to obtain an injection sample;

[0011] Performing liquid chromatography detection on the injected sample to obtain a target compound;

[0012] The conditions of the liquid chromatography detection are as follows: the chromatographic column adopts a reverse phase C18 chromatographic column, and the mobile phase includes mobile phase A and mobile phase B;

[0013] The mobile phase A is 2 to 10 mmol L −1 of an aqueous solution of ammonium acetate;

[0014] The mobile phase B is acetonitrile;

[0015] Adopting gradient elution for the mobile phase A and the mobile phase B;

[0016] Wherein, the liquid phase chromatography mass spectrometry conditions are: using an electrospray ion source;

[0017] The target compound includes at least one of the following compounds:

[0018] Perfluorobutanesulfonic acid, perfluoropentanesulfonic acid, 1-perfluorohexanesulfonic acid, br-perfluorohexanesulfonic acid, perfluoroheptanesulfonic acid, 1-perfluorooctanesulfonic acid, perfluoro-1-methylheptanesulfonic acid, perfluoro-6-methylheptanesulfonic acid, 3,4,5 m-perfluoroheptanesulfonic acid, Σm2-perfluorooctanesulfonic acid, perfluorononanesulfonic acid, perfluorodecanesulfonic acid, perfluorobutyric acid, perfluoropentanoic acid, perfluorohexanoic acid, perfluoroheptanesulfonic acid, perfluorooctanoic acid, perfluorononanoic acid, perfluorodecanoic acid, perfluoroundecanoic acid, perfluorododecanoic acid, perfluorotridecanoic acid, perfluorotetradecanoic acid, perfluorooctanesulfonamide, N-methyl perfluorooctanesulfonamidoacetic acid, N-ethyl perfluorooctanesulfonamidoacetic acid, 4:2 fluorotelomer sulfonic acid, 6:2 fluorotelomer sulfonic acid, 8:2 fluorotelomer sulfonic acid, 6:2 chlorinated polyfluoroether sulfonic acid, 8:2 Chlorinated polyfluoroether sulfonic acid, perfluoro-2-propoxypropionic acid, 4,8-dioxane-3H-perfluorononanoic acid.

[0019] Preferably, the step of obtaining an injection sample after pre-treating the follicular fluid sample comprises:

[0020] After adding the internal standard substance to the follicular fluid sample, add formic acid and mix well;

[0021] Waters Oasis HLB columns were used for loading after activation with methanol and formic acid;

[0022] Elution was performed by mechanical energy using formic acid, a mixture of formic acid and methanol, and ammonia, and collection was performed using ammonia and acetonitrile;

[0023] The eluate is concentrated by vacuum centrifugation to obtain the injection sample.

[0024] Preferably, the step of using gradient elution for the mobile phase A and the mobile phase B comprises:

[0025] The sum of mobile phase A and mobile phase B is 100%;

[0026] The initial proportion of mobile phase was 20% mobile phase B;

[0027] From 0 to 2 min, the volume percentage of mobile phase B increased from 20% to 40%;

[0028] From 2 to 10 min, the volume percentage of mobile phase B increased from 40% to 73.5%;

[0029] 10-10.1 min, the volume percentage of mobile phase B increased from 73.5% to 95%;

[0030] The equilibrium was maintained for 2.9 min. From 13 to 13.1 min, the volume percentage of mobile phase B returned to the initial condition from 95% and was maintained for 1.9 min.

[0031] Preferably, the concentration of formic acid is 0.1 mol / L;

[0032] And / or, in the mechanical energy elution using formic acid, a mixture of formic acid and methanol, and aqueous ammonia: when the formic acid and methanol are eluted together, the ratio of formic acid to water is 1:1 to 4:1, and the concentration of aqueous ammonia is 1%; the concentration of aqueous ammonia in the aqueous ammonia acetonitrile is 1%.

[0033] Preferably, the ammonia and acetonitrile are 1.5 to 2.5 mL.

[0034] Preferably, the reverse phase C18 chromatographic column is of Agilent ZORBAX Eclipse Plus C18;

[0035] Preferably, the column temperature of the chromatographic column is 30-45°C.

[0036] Preferably, the flow rate of the mobile phase is 0.4 mL / min;

[0037] Preferably, the electrospray ion source parameters are set as follows: ion source temperature 400° C., voltage 4500 V, and nebulizer pressure 30 psi.

[0038] The positive progressive effect of the present invention is that the method for detecting perfluoro and polyfluoroalkyl substances in follicular fluid is simple and rapid, has a low detection limit, strong versatility, high sensitivity, stability and good reproducibility through solid phase extraction and liquid chromatography of follicular fluid, and can detect 33 types of PFAS in follicular fluid. BRIEF DESCRIPTION OF THE DRAWINGS

[0039] Figure 1 This is a flow chart of the method for detecting perfluoro and polyfluoroalkyl substances in follicular fluid according to Example 1 of the present invention;

[0040] FIG2 (A) is a total ion current spectrum of the mass spectrometry results of 33 PFAS in the method for detecting per- and polyfluoroalkyl substances in a standard solution in Example 1 of the present invention;

[0041] FIG2 (B) is a total ion current spectrum of the mass spectrometry results of 33 PFASs in the method for detecting perfluoroalkyl and polyfluoroalkyl substances in follicular fluid according to Example 1 of the present invention. DETAILED DESCRIPTION

[0042] The present invention is further described below by way of examples, but the present invention is not limited to the scope of the examples.

[0043] In the description of the present invention, it should be understood that the terms "center", "longitudinal", "lateral", "length", "width", "thickness", "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inside", "outside", "clockwise", "counterclockwise" and the like indicate orientations or positional relationships based on the orientations or positional relationships shown in the accompanying drawings, and are only for the convenience of describing the present invention and simplifying the description, and do not indicate or imply that the referred device or element must have a specific orientation, be constructed and operated in a specific orientation, and therefore should not be understood as a limitation on the present invention.

[0044] In addition, the terms "first", "second", and "third" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features. Therefore, a feature defined as "first", "second", and "third" may explicitly or implicitly include one or more of the features. In the description of the present invention, the meaning of "plurality" is two or more, unless otherwise clearly and specifically defined.

[0045] Example 1

[0046] This embodiment provides a method for detecting perfluoroalkyl and polyfluoroalkyl substances in follicular fluid, such as Figure 1 As shown, the detection method comprises:

[0047] S101. Obtain follicular fluid sample:

[0048] S102, obtaining an injection sample after pre-processing the follicular fluid sample;

[0049] S103, performing liquid chromatography detection on the injected sample to obtain a target compound;

[0050] The conditions of the liquid chromatography detection are as follows: the chromatographic column adopts a reverse phase C18 chromatographic column, and the mobile phase includes mobile phase A and mobile phase B;

[0051] The mobile phase A is 2 to 10 mmol L −1 of an aqueous solution of ammonium acetate;

[0052] The mobile phase B is acetonitrile;

[0053] Adopting gradient elution for the mobile phase A and the mobile phase B;

[0054] Wherein, the liquid phase chromatography mass spectrometry conditions are: using an electrospray ion source;

[0055] The target compound includes at least one of the following compounds:

[0056] Perfluorobutanesulfonic acid, perfluoropentanesulfonic acid, 1-perfluorohexanesulfonic acid, br-perfluorohexanesulfonic acid, perfluoroheptanesulfonic acid, 1-perfluorooctanesulfonic acid, perfluoro-1-methylheptanesulfonic acid, perfluoro-6-methylheptanesulfonic acid, 3,4,5 m-perfluoroheptanesulfonic acid, Σm2-perfluorooctanesulfonic acid, perfluorononanesulfonic acid, perfluorodecanesulfonic acid, perfluorobutyric acid, perfluoropentanoic acid, perfluorohexanoic acid, perfluoroheptanesulfonic acid, perfluorooctanoic acid, perfluorononanoic acid, perfluorodecanoic acid, perfluoroundecanoic acid, perfluorododecanoic acid, perfluorotridecanoic acid, perfluorotetradecanoic acid, perfluorooctanesulfonamide, N-methyl perfluorooctanesulfonamidoacetic acid, N-ethyl perfluorooctanesulfonamidoacetic acid, 4:2 fluorotelomer sulfonic acid, 6:2 fluorotelomer sulfonic acid, 8:2 fluorotelomer sulfonic acid, 6:2 chlorinated polyfluoroether sulfonic acid, 8:2 Chlorinated polyfluoroether sulfonic acid, perfluoro-2-propoxypropionic acid, 4,8-dioxane-3H-perfluorononanoic acid.

[0057] As an implementable manner, step S102 includes:

[0058] After adding the internal standard substance to the follicular fluid sample, add formic acid and mix well;

[0059] Waters Oasis HLB columns were used for loading after activation with methanol and formic acid;

[0060] Elution was performed by mechanical energy using formic acid, a mixture of formic acid and methanol, and ammonia, and collection was performed using ammonia and acetonitrile;

[0061] The eluate is concentrated by vacuum centrifugation to obtain the injection sample.

[0062] The internal standard is added according to the detected target compound. The general requirement is that the internal standard should be a stable non-sample endogenous substance, and the retention time should be close to the retention time of the detected target compound, and the best is that the chemical properties are almost the same as the target compound. If there are multiple target compounds detected, and the retention times of each target compound differ greatly, multiple internal standards can be added to correspond to different retention time periods. When calculating the content of a certain target compound, the internal standard whose retention time is closer to that of the target compound should be used as a reference for calculation. Preferably, the internal standard can be an isotope label of the target compound, and an internal standard can be used to calculate the content of one or more detected target compounds whose retention times are closer to it.

[0063] As an achievable manner, the step of using gradient elution for the mobile phase A and the mobile phase B in step S103 includes:

[0064] The sum of mobile phase A and mobile phase B is 100%;

[0065] The initial proportion of mobile phase was 20% mobile phase B;

[0066] From 0 to 2 min, the volume percentage of mobile phase B increased from 20% to 40%;

[0067] From 2 to 10 min, the volume percentage of mobile phase B increased from 40% to 73.5%;

[0068] 10-10.1 min, the volume percentage of mobile phase B increased from 73.5% to 95%;

[0069] The equilibrium was maintained for 2.9 min. From 13 to 13.1 min, the volume percentage of mobile phase B returned to the initial condition from 95% and was maintained for 1.9 min.

[0070] As an achievable manner, the concentration of formic acid is 0.1 mol / L;

[0071] As an achievable method, in the mechanical energy elution using formic acid, a mixture of formic acid and methanol, or aqueous ammonia: when the formic acid and methanol are eluted together, the ratio of formic acid to water is 1:1 to 4:1; in one embodiment, the ratio of formic acid to water is 4:1

[0072] As a feasible manner, the concentration of the aqueous ammonia is 1%; the concentration of the aqueous ammonia in the aqueous ammonia acetonitrile is 1%.

[0073] As an achievable method, the ammonia acetonitrile is 1.5 to 2.5 mL. In one embodiment, the ammonia acetonitrile is 1.8 mL.

[0074] As a feasible method, the reverse phase C18 chromatographic column is Agilent ZORBAX EclipsePlus C18 (2.1 × 50 mm, 1.8 μm);

[0075] As a feasible manner, the column temperature of the chromatographic column is 30-45°C.

[0076] As an achievable manner, the mobile phase flow rate is 0.4 mL / min;

[0077] As a feasible method, the electrospray ion source parameters are set as follows: ion source temperature 400° C., voltage 4500 V, and nebulizer pressure 30 psi.

[0078] The working principle of the training method of the medical image classification model in this embodiment is specifically described below with an example:

[0079] The following steps are involved:

[0080] 1) Sample pretreatment:

[0081] 200 uL follicular fluid, add 2 ng internal standard, then add 1 mL 0.1M formic acid, mix well; use Oasis HLB column for SPE (Solid-Phase Extraction), activate the column with 1 mL methanol and 1 mL 0.1M formic acid, load the sample, then add 1 mL 0.1M formic acid, 3 mL 0.1M formic acid: methanol (4:1), 0.5 mL 1% ammonia water for elution, wait for natural flow, vacuum pump for 30 min, add 1.8mL ammonia acetonitrile for elution, collect the eluate; transfer the eluate to a centrifugal concentrator, concentrate at 40℃ for 2h, reconstitute with 100 μL 60% methanol, and detect on the machine, with an injection volume of 5 μL;

[0082] 2) Select the HPLC column and set the mass spectrometry conditions and parameters:

[0083] a. The ultra-high performance liquid phase conditions are as follows: the chromatographic column uses a reverse phase C18 chromatographic column; the mobile phase includes mobile phase A and mobile phase B; mobile phase A is a 2 mmol / L ammonium acetate solution; mobile phase B is acetonitrile; gradient elution is used, and the gradient elution program is carried out according to the following procedures: the sum of mobile phase A and mobile phase B is 100%; the initial proportion of mobile phase is 20% mobile phase B; from 0 to 2 min, the volume percentage of mobile phase B increases from 20% to 40%; from 2 to 10 min, the volume percentage of mobile phase B increases from 40% to 73.5%; from 10 to 10.1 min, the volume percentage of mobile phase B increases from 73.5% to 95%; the balance is maintained for 2.9 min; from 13 to 13.1 min, the volume percentage of mobile phase B returns to the initial condition from 95% and is maintained for 1.9 min;

[0084] b. The detection mass spectrometry conditions are: using ESI (Electron Spray Ionization) source DMRM (Dynamic Multi-Response Detection) negative ion mode, the ion source parameters of the mass spectrometry conditions are set as follows: ion source temperature 400 °C, voltage 4500V, nebulizer pressure 30 psi;

[0085] The method of the present invention can detect 33 target compounds in follicular fluid for quantitative detection and analysis. The ion pair information in the mass spectrum is shown in Table 1, in which the corresponding internal standard compounds are indicated.

[0086]

[0087]

[0088]

[0089] The mass spectrometry results of detecting 33 PFAS using the method of the present invention are shown in FIG2 .

[0090] Figure 2 (A) shows the total ion current spectrum of 33 PFAS in the mixed standard solution (PFAS dissolved in 60% methanol, concentration of 10 ng mL −1 ); Figure 2 (B) shows the total ion current spectrum of the follicular fluid after pre-treatment.

[0091] The quality of the liquid chromatography column test results was investigated by limit of detection (LOD), limit of quantitation (LOQ), linearity, recovery, intra-day precision and inter-day precision.

[0092] Investigation of LOD and LOQ

[0093] LOD investigation: The LOD and LOQ values ​​of 33 target compounds were investigated using the method of the present invention. The LOD and LOQ of the method were obtained after the samples were pre-treated. The smaller the LOD value, the higher the detection sensitivity. The test results are shown in Table 2:

[0094]

[0095]

[0096] a Sum of dimethyl isomers of perfluorooctane sulfonate

[0097] The experimental results show that when the method of the present invention is used to detect the above 33 PFAS compounds, the LOD value is between 0.0023 and 0.1461 ng mL −1 Within this range, it can meet the detection requirements of 33 PFAS compounds in actual clinical follicular fluid samples.

[0098] Linear inspection

[0099] Linearity test: The standard curve in the present invention is directly prepared in the solution, using 60% methanol as the solution, and preparing 0.01-100 ng mL −1 The standard solution was used for 3 consecutive days to make 3 batches of 33 compounds to examine the linear correlation. The results are shown in Table 3:

[0100]

[0101]

[0102] a Sum of dimethyl isomers of perfluorooctane sulfonate

[0103] The experimental results show that the concentration of each compound is between 0.01 and 100 ng mL −1 Good linearity within the range, linear correlation coefficient R 2 >0.990, the method of the present invention has high accuracy in quantitative detection of the above 33 PFAS.

[0104] Recovery rate, intra-day precision and inter-day precision investigation:

[0105] Recovery rate: 6 groups of spiked samples with low and high concentrations (1 ng / mL, 10 ng / mL) were prepared on the same day, and the recovery rate of each quality control was calculated;

[0106] Intra-day precision: Six groups of low and high (1 ng / mL, 10 ng / mL) concentration spiked samples were prepared on the same day, and the standard deviation of each quality control was calculated ( RSD) and recovery rate

[0107] Daily precision: 6 batches of quality control samples were prepared for 6 consecutive days. Each batch was prepared with two concentrations (1 ng / mL and 10 ng / mL) and 3 parallel samples for each batch. The precision of each quality control was calculated. RSD The results are shown in Table 4:

[0108]

[0109]

[0110] a Sum of dimethyl isomers of perfluorooctane sulfonate

[0111] The method for detecting perfluoro and polyfluoroalkyl substances in follicular fluid provided in this embodiment has the characteristics of simplicity and rapidity, low detection limit, strong versatility, high sensitivity, stability and good reproducibility through solid phase extraction and liquid chromatography detection of follicular fluid, and can detect 33 types of PFAS in follicular fluid.

[0112] Although the specific embodiments of the present invention are described above, it should be understood by those skilled in the art that this is only for illustration and the protection scope of the present invention is defined by the appended claims. Those skilled in the art may make various changes or modifications to these embodiments without departing from the principles and essence of the present invention, but these changes and modifications all fall within the protection scope of the present invention.

Claims

1. A method for detecting perfluoroalkyl and polyfluoroalkyl substances in follicular fluid, characterized in that: The detection method comprises: Obtaining a follicular fluid sample: The follicular fluid sample is pretreated to obtain an injection sample, comprising: After adding the internal standard substance to the follicular fluid sample, add formic acid and mix well; Waters Oasis HLB columns were used for loading after activation with methanol and formic acid; Add formic acid, a mixture of formic acid and methanol, and aqueous ammonia to wash in sequence, add aqueous ammonia and acetonitrile to elute, and collect the eluate; Concentrating the eluate by vacuum centrifugation to obtain the injection sample; Performing liquid chromatography-mass spectrometry detection on the injected sample to obtain a target compound; The conditions of the liquid chromatography detection are as follows: the chromatographic column adopts a reverse phase C18 chromatographic column, and the mobile phase includes mobile phase A and mobile phase B; The mobile phase A is a 2-10 mmol L−1 ammonium acetate aqueous solution; The mobile phase B is acetonitrile; Adopting gradient elution for the mobile phase A and the mobile phase B; The step of using gradient elution for the mobile phase A and the mobile phase B comprises: The sum of mobile phase A and mobile phase B is 100%; The initial proportion of mobile phase was 20% mobile phase B; From 0 to 2 min, the volume percentage of mobile phase B increased from 20% to 40%; From 2 to 10 min, the volume percentage of mobile phase B increased from 40% to 73.5%; 10-10.1 min, the volume percentage of mobile phase B increased from 73.5% to 95%; The balance was maintained for 2.9 min. From 13 to 13.1 min, the volume percentage of mobile phase B returned to the initial condition from 95% and was maintained for 1.9 min. Wherein, the chromatographic detection mass spectrometry conditions of the liquid phase are: using an electrospray ion source in negative ion mode; The target compound includes at least one of the following compounds: Perfluorobutanesulfonic acid, perfluoropentanesulfonic acid, 1-perfluorohexanesulfonic acid, br-perfluorohexanesulfonic acid, perfluoroheptanesulfonic acid, 1-perfluorooctanesulfonic acid, perfluoro-1-methylheptanesulfonic acid, perfluoro-6-methylheptanesulfonic acid, 3,4,5 m-perfluoroheptanesulfonic acid, Σm2-perfluorooctanesulfonic acid, perfluorononanesulfonic acid, perfluorodecanesulfonic acid, perfluorobutyric acid, perfluoropentanoic acid, perfluorohexanoic acid, perfluoroheptanesulfonic acid, perfluorooctanoic acid, perfluorononanoic acid, perfluorodecanoic acid, perfluoroundecanoic acid, perfluorododecanoic acid, perfluorotridecanoic acid, perfluorotetradecanoic acid, perfluorooctanesulfonamide, N-methyl perfluorooctanesulfonamidoacetic acid, N-ethyl perfluorooctanesulfonamidoacetic acid, 4:2 fluorotelomer sulfonic acid, 6:2 fluorotelomer sulfonic acid, 8:2 fluorotelomer sulfonic acid, 6:2 chlorinated polyfluoroether sulfonic acid, 8:2 Chlorinated polyfluoroether sulfonic acid, perfluoro-2-propoxypropionic acid, 4,8-dioxane-3H-perfluorononanoate.

2. The method for detecting perfluoroalkyl and polyfluoroalkyl substances in follicular fluid according to claim 1, characterized in that: After adding the internal standard substance to the follicular fluid sample, formic acid is added: the concentration of the formic acid is 0.1 mol / L; And / or, formic acid, a mixture of formic acid and methanol and aqueous ammonia are added in sequence for elution: when the formic acid and methanol are eluted together, the ratio of formic acid to methanol is 4:1, and the concentration of aqueous ammonia is 1%; the concentration of aqueous ammonia in the aqueous ammonia acetonitrile is 1%.

3. The method for detecting perfluoroalkyl and polyfluoroalkyl substances in follicular fluid according to claim 1, characterized in that: The model of the reverse phase C18 chromatographic column is Agilent ZORBAX Eclipse Plus C18.

4. The method for detecting perfluoroalkyl and polyfluoroalkyl substances in follicular fluid according to claim 1, characterized in that: The column temperature of the chromatographic column is 30-45°C.

5. The method for detecting perfluoroalkyl and polyfluoroalkyl substances in follicular fluid according to claim 1, characterized in that: The flow rate of the mobile phase in the chromatographic column was 0.4 mL / min.

6. The method for detecting perfluoroalkyl and polyfluoroalkyl substances in follicular fluid according to claim 1, characterized in that: The electrospray ion source parameters were set as follows: ion source temperature 400°C, voltage 4500 V, and nebulizer pressure 30 psi.

Citation Information

Patent Citations

  • Immunoaffinity chromatography-ultrahigh performance liquid chromatography-mass spectrum combined rapid detection method for perfluorinated compounds in dairy products

    CN103487515A

  • Method for detecting perfluoroalkanoic acid compound in aquatic product by enrichment purification-liquid chromatography tandem mass spectrometry and application

    CN112684030A

  • Method for simultaneously determining 21 perfluorinated compound residues in animal-derived food by ultra-high performance liquid chromatography-tandem mass spectrometry

    CN116026977A

  • Detection method based on supercritical fluid chromatography and post-column ionic liquid charge complexation

    US20220229027A1

  • Method for analyzing targeted exposure group of environmental pollutants in plasma, and use thereof

    WO2023005682A1